Literature DB >> 30203046

Chemical Activation of the Constitutive Androstane Receptor Leads to Activation of Oxidant-Induced Nrf2.

John P Rooney1,2, Keiyu Oshida1,3, Ramiya Kumar4, William S Baldwin4, J Christopher Corton1.   

Abstract

Exposure to environmentally relevant chemicals that activate the xenobiotic receptors aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), and peroxisome proliferator-activated receptor alpha (PPARα) in rodent test systems often leads to increases in oxidative stress (OS) that contributes to liver cancer induction. We hypothesized that activation of the oxidant-induced transcription factor Nrf2 could be used as a surrogate endpoint for increases in OS. We examined the relationships between activation of xenobiotic receptors and Nrf2 using previously characterized gene expression biomarkers that accurately predict modulation. Using a correlation approach (Running Fisher Test), the biomarkers were compared with microarray profiles in a mouse liver gene expression compendium. Out of the 163 chemicals examined, 47% from 53 studies activated Nrf2. We found consistent coupling between CAR and Nrf2 activation. Out of the 41 chemicals from 32 studies that activated CAR, 90% also activated Nrf2. CAR was activated earlier and at lower doses than Nrf2, indicating CAR activation preceded Nrf2 activation. Nrf2 activation by 2 CAR activators was abolished in CAR-null mice. We hypothesized that Nrf2 is activated by reactive oxygen species from the increased activity of enzymes encoded by Cyp2b family members. However, Nrf2 was similarly activated in the livers of both TCPOBOP-treated wild-type and Cyp2b9/10/13-null mice. This study provides evidence that Nrf2 activation (1) often occurs after exposure to xenobiotic chemicals, (2) is tightly linked to activation of CAR, and (3) does not require induction of 3 Cyp2b genes secondary to CAR activation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30203046      PMCID: PMC6317430          DOI: 10.1093/toxsci/kfy231

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  58 in total

Review 1.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

Authors:  Thomas W Kensler; Nobunao Wakabayashi; Shyam Biswal
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  Constitutive androstane receptor -null mice are sensitive to the toxic effects of parathion: association with reduced cytochrome p450-mediated parathion metabolism [corrected].

Authors:  Linda C Mota; Juan P Hernandez; William S Baldwin
Journal:  Drug Metab Dispos       Date:  2010-06-23       Impact factor: 3.922

3.  Lentiviral-mediated RNAi knockdown yields a novel mouse model for studying Cyp2b function.

Authors:  Basma Damiri; Eric Holle; Xianzhong Yu; William S Baldwin
Journal:  Toxicol Sci       Date:  2011-11-14       Impact factor: 4.849

4.  Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.

Authors:  I Rusyn; S Yamashina; B H Segal; R Schoonhoven; S M Holland; R C Cattley; J A Swenberg; R G Thurman
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

5.  PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.

Authors:  Mitchell B Rosen; Kaberi P Das; John Rooney; Barbara Abbott; Christopher Lau; J Christopher Corton
Journal:  Toxicology       Date:  2017-05-27       Impact factor: 4.221

6.  Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.

Authors:  Sumio Ohtsuki; Olaf Schaefer; Hirotaka Kawakami; Tae Inoue; Stephanie Liehner; Asami Saito; Naoki Ishiguro; Wataru Kishimoto; Eva Ludwig-Schwellinger; Thomas Ebner; Tetsuya Terasaki
Journal:  Drug Metab Dispos       Date:  2011-10-12       Impact factor: 3.922

7.  Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.

Authors:  Melinda S Yates; Quynh T Tran; Patrick M Dolan; William O Osburn; Soona Shin; Colin C McCulloch; Jay B Silkworth; Keiko Taguchi; Masayuki Yamamoto; Charlotte R Williams; Karen T Liby; Michael B Sporn; Thomas R Sutter; Thomas W Kensler
Journal:  Carcinogenesis       Date:  2009-04-21       Impact factor: 4.944

8.  Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation.

Authors:  Susumu Imaoka; Mayuko Osada; Yukiko Minamiyama; Tokihito Yukimura; Shinya Toyokuni; Shigekazu Takemura; Toyoko Hiroi; Yoshihiko Funae
Journal:  Cancer Lett       Date:  2004-01-20       Impact factor: 8.679

9.  Analyzing microarray data with transitive directed acyclic graphs.

Authors:  Vinhthuy Phan; E Olusegun George; Quynh T Tran; Shirlean Goodwin; Sridevi Bodreddigari; Thomas R Sutter
Journal:  J Bioinform Comput Biol       Date:  2009-02       Impact factor: 1.122

10.  Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers.

Authors:  Tamara R Knight; Supratim Choudhuri; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-22       Impact factor: 4.849

View more
  8 in total

1.  Widespread epigenetic changes to the enhancer landscape of mouse liver induced by a specific xenobiotic agonist ligand of the nuclear receptor CAR.

Authors:  Andy Rampersaud; Nicholas J Lodato; Aram Shin; David J Waxman
Journal:  Toxicol Sci       Date:  2019-06-24       Impact factor: 4.849

2.  Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis.

Authors:  Melissa M Heintz; Ramiya Kumar; Meredith M Rutledge; William S Baldwin
Journal:  J Nutr Biochem       Date:  2019-05-21       Impact factor: 6.048

3.  Phase 0 of the Xenobiotic Response: Nuclear Receptors and Other Transcription Factors as a First Step in Protection from Xenobiotics.

Authors:  William S Baldwin
Journal:  Nucl Receptor Res       Date:  2019-11-20

4.  Considerations for Strategic Use of High-Throughput Transcriptomics Chemical Screening Data in Regulatory Decisions.

Authors:  Joshua Harrill; Imran Shah; R Woodrow Setzer; Derik Haggard; Scott Auerbach; Richard Judson; Russell S Thomas
Journal:  Curr Opin Toxicol       Date:  2019

5.  Sex-, Age-, and Race/Ethnicity-Dependent Variations in Drug-Processing and NRF2-Regulated Genes in Human Livers.

Authors:  Jie Liu; Julia Yue Cui; Yuan-Fu Lu; J Christopher Corton; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2020-11-08       Impact factor: 3.922

6.  Application of a Rat Liver Drug Bioactivation Transcriptional Response Assay Early in Drug Development That Informs Chemically Reactive Metabolite Formation and Potential for Drug-induced Liver Injury.

Authors:  James J Monroe; Keith Q Tanis; Alexei A Podtelezhnikov; Truyen Nguyen; Sam V Machotka; Donna Lynch; Raymond Evers; Jairam Palamanda; Randy R Miller; Todd Pippert; Tamara D Cabalu; Timothy E Johnson; Amy G Aslamkhan; Wen Kang; Alex M Tamburino; Kaushik Mitra; Nancy G B Agrawal; Frank D Sistare
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

7.  Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats.

Authors:  Fatemeh Alaei Faradonbeh; Hana Lastuvkova; Jolana Cermanova; Milos Hroch; Zuzana Nova; Martin Uher; Petra Hirsova; Petr Pavek; Stanislav Micuda
Journal:  Front Physiol       Date:  2022-03-21       Impact factor: 4.755

8.  A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies.

Authors:  J Christopher Corton; Constance A Mitchell; Scott Auerbach; Pierre Bushel; Heidrun Ellinger-Ziegelbauer; Patricia A Escobar; Roland Froetschl; Alison H Harrill; Kamin Johnson; James E Klaunig; Arun R Pandiri; Alexei A Podtelezhnikov; Julia E Rager; Keith Q Tanis; Jan Willem van der Laan; Alisa Vespa; Carole L Yauk; Syril D Pettit; Frank D Sistare
Journal:  Toxicol Sci       Date:  2022-06-28       Impact factor: 4.109

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.